Introducing the Run Free Cure Cancer Charity Partnership
Between the Love Run Philadelphia Marathon and Legacy of Hope
The Love Run Philadelphia Half Marathon is proud to partner with the Legacy of Hope as the 2019 official charity partner. Together, our goal is to raise $250,000 in 2019 to not only fight cancer but to cure our region of it for good.
All of us have been touched by cancer in some way and this is our opportunity to use what we love (running) as a platform to raise funds and rid Philadelphia and the region of cancer.
Great news you can be part of the Run Free Cure Cancer program AND race with your team too!
Here’s how you can run free at the Love Run Philadelphia Half Marathon this year:
- Simply register now and select Legacy of Hope Run For Free, choose your distance, and follow the online registration process.
- Upon completion you will get a confirmation with a link to the LEGACY OF HOPE Crowdrise page.
- Go to the link, set up your page, and start fundraising!
Fortunately, you won’t be responsible for raising all $250,000 yourself. Each participant will be asked to raise a minimum of $200. Once you reach your goal, you will be refunded your ENTIRE ENTRY FEE (and processing fees)! Of course, you are more than welcome – and encouraged! – to raise more than the required minimum.
Already registered? Don’t worry, you haven’t missed out on supporting this amazing cause. Simply click here to be directed to the Legacy of Hope fundraising page where you can start your page and start your fundraising now.
Learn more about Legacy of Hope
Register for the 2019 Love Run Philadelphia Half Marathon so Philly can be cancer free!
#loverunphilly #loverunFREE #phillyrunsfree
**If you select any add-on options – such as mail my packet – you will not be reimbursed for those fees.
We’re proud to partner with these great brands to bring you an incredible event experience. Whether you’re drenched in sweat, dressed in costume or immersed in music, you've worked hard to get there and deserve to have the best time possible.